The 24.2% average weight loss achieved with Retatrutide approaches the results typically seen with bariatric surgery
MOTS-c is usually cycled: 4-8 weeks on, 2-4 weeks off, repeated through the retatrutide cycle
Competing Interests The authors declare no competing interests
Prescribing information describes gastrointestinal adverse reactions as common, particularly during dose escalation, and clinicians typically individualize titration based on tolerability and patient history
However, a Precision Peptide Genetic Test from PlexusDx can provide context about your peptide-pathway predispositions and support a more informed conversation with your provider about expected response patterns and tolerability
En EEUU, 1 de cada 8 adultos informa que actualmente est tomando un medicamento GLP-1 para la prdida de peso u otra condicin como la diabetes, segn KFF, un grupo de reflexin sobre salud sin fines de lucro